Evidence map›Paper›PMID 32612923›Full record

ArticleLeukemia research reports2020

Isolated pulmonary vasculitis associated with nilotinib use: A case report.

Nicolette T Morris, Mihaela B Taylor, Melkon Hacobian, Olga M Olevsky, Tanaz A Kermani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nicolette T MorrisDivision of Rheumatology, University of California, Los Angeles, David Geffen School of Medicine, California, USA.
Mihaela B TaylorDivision of Rheumatology, University of California, Los Angeles, David Geffen School of Medicine, California, USA.
Melkon HacobianUniversity of California, Los Angeles, David Geffen School of Medicine, California, USA.
Olga M OlevskyDivision of Hematology, University of California, Los Angeles, David Geffen School of Medicine, California, USA.
Tanaz A KermaniDivision of Rheumatology, University of California, Los Angeles, David Geffen School of Medicine, California, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An association between tyrosine-kinase inhibitor therapy for chronic myeloid leukemia and vascular adverse events including peripheral arterial disease, coronary artery disease, and pulmonary hypertension has been described. We present a patient who developed isolated pulmonary artery vasculitis resulting in left pulmonary artery stenosis, in addition to left coronary artery stenosis while on nilotinib. While monitoring for cardiovascular events is important, clinicians should also recognize possible drug-induced vasculitis during chronic nilotinib therapy.

Indexed as

ArteritisChronic myeloid leukemiaLarge vessel vasculitisNilotinibPulmonary arteritisPulmonary vasculitisTyrosine kinase inhibitorVascular adverse eventsVasculitis

Identifiers

PMID32612923
PMCPMC7322170
OpenAlexW3036566375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.